# Aptar Pharma completes first phase of $180M global expansion program

Aptar Pharma completed the first phase of its approximately $180 million expansion program, adding over 23,000 square meters of manufacturing footprint in France and the U.S. to boost capacity for injection system components, including PremiumCoat film-coated components and elastomer components.

- Type: Expansion
- Announced: 2022-12-28
- Where: Granville, France, France
- Value: $180.0M
- Starts operating: 28 Dec 2022
- Status: completed
- Products: injection system components, PremiumCoat ETFE film-coated components, PremiumFill enhanced specification solutions, elastomer components, vial stoppers
- Sectors: [Packaging](https://endata.com/sectors/packaging.md), [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Aptar Pharma](https://endata.com/companies/1969.md)

## Sources

- [healthcarepackaging.com](https://www.healthcarepackaging.com/machinery/packaging-filling/news/22618485/aptar-pharma-aptar-pharma-completes-first-phase-of-global-expansion-program), 2022-12-28: "The investments will add new digitalized processes and expand the company’s manufacturing capacity to meet growing customer needs."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.